XML 37 R27.htm IDEA: XBRL DOCUMENT v3.25.3

Revenues (Tables)

9 Months Ended

Sep. 30, 2025

Revenues [Abstract]

Revenues

During the three and nine months ended September 30, 2025 and 2024, our revenues consisted of the following (in thousands):

	Three Months Ended								Nine Months Ended
	September 30,								September 30,
		2025				2024				2025				2024
Revenue:
Commercial revenue:
Product sales, net:
TRYNGOLZA sales, net	$	31,792			$	-			$	57,353			$	-
Total product sales, net		31,792				-				57,353				-
Royalty revenue:
SPINRAZA royalties		55,896				57,208				158,243				152,406
WAINUA royalties		13,320				5,371				33,107				10,278
Other royalties		6,478				4,228				18,461				17,352
Total royalty revenue		75,694				66,807				209,811				180,036
Other commercial revenue		8,112				8,924				27,359				27,324
Total commercial revenue		115,598				75,731				294,523				207,360
Research and development revenue:
Collaborative agreement revenue		31,436				44,883				413,387				235,753
WAINUA joint development revenue		9,685				13,200				32,471				35,449
Total research and development revenue		41,121				58,083				445,858				271,202
Total revenue	$	156,719			$	133,814			$	740,381			$	478,562

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration